Accelerating Progress in Pediatric Cancer
NCI is pushing the “bench to bedside” paradigm to bring medical advances into the clinic.
Pediatric cancers are considered rare diseases, which makes them more challenging to study and treat. However, efforts like the Childhood Cancer Data Initiative are helping to further disease biology understanding and open pathways for community collaboration. In light of Childhood Cancer Awareness Month, NCI experts discuss the future of advancements such as precision medicine and immunotherapy.
-
Dr. Nirali Shah Hematologic Malignancies Section Head, Pediatric Oncology NCI -
Dr. Christine Heske Translational Sarcoma Biology Group Head, Pediatric Oncology NCI
-
Humanizing Cybersecurity Through a ‘Safer Shift’
Cybersecurity isn’t just tech. Safer Shift’s Tiziana Barrow shares how storytelling can make digital safety intuitive and human.
24m watch -
Staying Ahead of AI-Driven Cyber Threats
Robert Roser shares insights on emerging cybercrime trends, supply chain risks and how federal organizations can build stronger security through zero trust.
8m watch -
Marine Corps’ Project Dynamis Speeds AI for Future Battlefield Operations
Col. Arlon Smith shares how Project Dynamis is helping the Marine Corps rapidly field AI capabilities and operate in a future dominated by autonomous systems.
5m listen -
CMS Advances Zero Trust, AI Security in IT Modernization Push
The agency is consolidating platforms to improve security and efficiency.
10m watch
